Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 10
2019 5
2020 13
2021 11
2022 6
2023 20
2024 48
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment.
Petersen M, Coenen M, DeCarli C, De Luca A, van der Lelij E; Alzheimer’s Disease Neuroimaging Initiative; Barkhof F, Benke T, Chen CPLH, Dal-Bianco P, Dewenter A, Duering M, Enzinger C, Ewers M, Exalto LG, Fletcher EM, Franzmeier N, Hilal S, Hofer E, Koek HL, Maier AB, Maillard PM, McCreary CR, Papma JM, Pijnenburg YAL, Schmidt R, Smith EE, Steketee RME, van den Berg E, van der Flier WM, Venkatraghavan V, Venketasubramanian N, Vernooij MW, Wolters FJ, Xu X, Horn A, Patil KR, Eickhoff SB, Thomalla G, Biesbroek JM, Biessels GJ, Cheng B. Petersen M, et al. Brain. 2024 Dec 3;147(12):4265-4279. doi: 10.1093/brain/awae315. Brain. 2024. PMID: 39400198 Free PMC article.
A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.
Tosun D, Hausle Z, Iwaki H, Thropp P, Lamoureux J, Lee EB, MacLeod K, McEvoy S, Nalls M, Perrin RJ, Saykin AJ, Shaw LM, Singleton AB, Lebovitz R, Weiner MW, Blauwendraat C; Alzheimer's Disease Neuroimaging Initiative. Tosun D, et al. Alzheimers Dement. 2024 Aug;20(8):5114-5131. doi: 10.1002/alz.13858. Epub 2024 May 21. Alzheimers Dement. 2024. PMID: 38770829 Free PMC article.
Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease.
Quesnel MJ, Labonté A, Picard C, Bowie DC, Zetterberg H, Blennow K, Brinkmalm A, Villeneuve S, Poirier J; Alzheimer's Disease Neuroimaging Initiative; PREVENT‐AD Research Group. Quesnel MJ, et al. Alzheimers Dement. 2024 Sep;20(9):6008-6031. doi: 10.1002/alz.14065. Epub 2024 Jul 28. Alzheimers Dement. 2024. PMID: 39072932 Free PMC article.
Biomarker pathway heterogeneity of amyloid-positive individuals.
Prosser L, Sudre CH, Oxtoby NP, Young AL, Malone IB, Manning EN, Pemberton H, Walsh P, Barkhof F, Biessels GJ, Cash DM, Barnes J; Alzheimer's Disease Neuroimaging Initiative. Prosser L, et al. Alzheimers Dement. 2024 Dec;20(12):8503-8515. doi: 10.1002/alz.14287. Epub 2024 Oct 17. Alzheimers Dement. 2024. PMID: 39417393 Free PMC article.
Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis.
Howe MD, Caruso MR, Manoochehri M, Kunicki ZJ, Emrani S, Rudolph JL, Huey ED, Salloway SP, Oh H; Alzheimer's Disease Neuroimaging Initiative. Howe MD, et al. Alzheimers Dement. 2024 Oct;20(10):7220-7231. doi: 10.1002/alz.14207. Epub 2024 Sep 1. Alzheimers Dement. 2024. PMID: 39219209 Free PMC article.
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
Hansson O, Cullen N, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Mattsson-Carlgren N. Hansson O, et al. Ann Clin Transl Neurol. 2021 Jan;8(1):259-265. doi: 10.1002/acn3.51253. Epub 2020 Nov 29. Ann Clin Transl Neurol. 2021. PMID: 33249783 Free PMC article.
108 results